Langerhans cells: Central players in the pathophysiology of atopic dermatitis
Journal of the European Academy of Dermatology and Venereology · 2025-02 · 39 (2) · 278-289
DOI: 10.1111/jdv.20291 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 19.08.2024. Verfasst von Yi Pan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Langerhans Cells, Dermatitis, Atopic. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Biocelline Enterprise Co. Ltd, China, CK-CARE of the Kühne Foundation, Switzerland, China Scholarship Council.
Abstract (Originalsprache)
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease worldwide. AD is a highly complex disease with different subtypes. Many elements of AD pathophysiology have been described, but if/how they interact with each other or which mechanisms are important in which patients is still unclear. Langerhans cells (LCs) are antigen‐presenting cells (APCs) in the epidermis. Depending on the context, they can act either pro‐ or anti‐inflammatory. Many different studies have investigated LCs in the context of AD and found them to be connected to all major mechanisms of AD pathophysiology. As APCs, LCs recruit other immune cells and shape the immune response, especially adaptive immunity via polarization of T cells. As sentinel cells, LCs are primary sensors of the skin microbiome and are important for the decision of immunity versus tolerance. LCs are also involved with the integrity of the skin barrier by influencing tight junctions. Finally, LCs are important cells in the neuro‐immune crosstalk in the skin. In this review, we provide an overview about the many different roles of LCs in AD. Understanding LCs might bring us closer to a more complete understanding of this highly complex disease. Potentially, modulating LCs might offer new options for targeted therapies for AD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology and Allergy, University Hospital of Bonn, Bonn, Germany.
- Department of Dermatology and Venerology, Medical University of Graz, Graz, Austria.
- Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University, Shanghai, China.
- Institute of Science and Technology Austria (IST Austria), Klosterneuburg, Austria.
- CK-CARE, Medicine Campus, Davos, Switzerland.
- Department of Dermatology, University Hospital of Zürich, Zürich, Switzerland.
ORCID-Profile: Yi Pan, Mathias Hochgerner, Małgorzata Anna Cichoń, Theresa Benezeder, Thomas Bieber, Peter Wolf
Förderung
- Shanghai Biocelline Enterprise Co. Ltd, China
- CK-CARE of the Kühne Foundation, Switzerland
- China Scholarship Council
Zitieren
APA
Pan, Y., Hochgerner, M., Cichoń, M. A., Benezeder, T., Bieber, T., & Wolf, P. (2025). Langerhans cells: Central players in the pathophysiology of atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 39(2), 278-289. https://doi.org/10.1111/jdv.20291
Vancouver
Pan Y, Hochgerner M, Cichoń MA, Benezeder T, Bieber T, Wolf P. Langerhans cells: Central players in the pathophysiology of atopic dermatitis. Journal of the European Academy of Dermatology and Venereology. 2025;39(2):278-289. doi:10.1111/jdv.20291
BibTeX
@article{Pan2025,
author = {Pan, Yi and Hochgerner, Mathias and Cichoń, Małgorzata Anna and Benezeder, Theresa and Bieber, Thomas and Wolf, Peter},
title = {Langerhans cells: Central players in the pathophysiology of atopic dermatitis},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2025},
volume = {39},
number = {2},
pages = {278--289},
doi = {10.1111/jdv.20291}
}
EUVIMED